SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001144204-18-052510
Filing Date
2018-10-04
Accepted
2018-10-04 16:30:56
Documents
5
Period of Report
2018-10-04
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K tv504240_8k.htm 8-K 24048
2 EXHIBIT 1.1 tv504240_ex1-1.htm EX-1.1 186575
3 EXHIBIT 5.1 tv504240_ex5-1.htm EX-5.1 11767
4 GRAPHIC tv504240_ex5-1img1.jpg GRAPHIC 6537
5 GRAPHIC tv504240_ex5-1img2.jpg GRAPHIC 11916
  Complete submission text file 0001144204-18-052510.txt   249356
Mailing Address 200 CONNELL DRIVE SUITE 1500 BERKELEY HEIGHTS NJ 07922
Business Address 200 CONNELL DRIVE SUITE 1500 BERKELEY HEIGHTS NJ 07922 908-517-7330
Cyclacel Pharmaceuticals, Inc. (Filer) CIK: 0001130166 (see all company filings)

IRS No.: 911766850 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-50626 | Film No.: 181108190
SIC: 2834 Pharmaceutical Preparations
Assistant Director 1